A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV | MicrobiomeTrials← Back to trialsNCT07392372
A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-02-09Est. Completion: 2026-11
Enrollment target: 67 participants Locations- Cook County Health, Chicago, Illinois, United States
- Johns Hopkins, Baltimore, Maryland, United States
- Washington University, St Louis, Missouri, United States
- Columbia University, New York, New York, United States
- UK Köln, Cologne, Germany
- CRS Mannheim, Mannheim, Germany
Other microbiome trials you might be interested in
HivOpioid Use
The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in th…
New Haven, United StatesEst. completion Dec 2028
HIV InfectionsPregnancy RelatedDepression, Anxiety
The purpose of this study is to develop a multi-level PrEP adherence and persistence intervention as an adaptation of th…
Harare, ZimbabweEst. completion Jan 1, 2027
Phase 1
Recruiting
The purpose of this study is to advance pediatric HIV treatment and cure research by evaluating the impact of a combinat…
Francistown, BotswanaEst. completion Sep 3, 2027